Nopp, S.; van der Bent, M.L.; Kraemmer, D.; Königsbrügge, O.; Wojta, J.; Pabinger, I.; Ay, C.; Nossent, A.Y.
Circulatory miR-411-5p as a Novel Prognostic Biomarker for Major Adverse Cardiovascular Events in Patients with Atrial Fibrillation. Int. J. Mol. Sci. 2023, 24, 3861.
https://doi.org/10.3390/ijms24043861
AMA Style
Nopp S, van der Bent ML, Kraemmer D, Königsbrügge O, Wojta J, Pabinger I, Ay C, Nossent AY.
Circulatory miR-411-5p as a Novel Prognostic Biomarker for Major Adverse Cardiovascular Events in Patients with Atrial Fibrillation. International Journal of Molecular Sciences. 2023; 24(4):3861.
https://doi.org/10.3390/ijms24043861
Chicago/Turabian Style
Nopp, Stephan, M. Leontien van der Bent, Daniel Kraemmer, Oliver Königsbrügge, Johann Wojta, Ingrid Pabinger, Cihan Ay, and Anne Yaël Nossent.
2023. "Circulatory miR-411-5p as a Novel Prognostic Biomarker for Major Adverse Cardiovascular Events in Patients with Atrial Fibrillation" International Journal of Molecular Sciences 24, no. 4: 3861.
https://doi.org/10.3390/ijms24043861
APA Style
Nopp, S., van der Bent, M. L., Kraemmer, D., Königsbrügge, O., Wojta, J., Pabinger, I., Ay, C., & Nossent, A. Y.
(2023). Circulatory miR-411-5p as a Novel Prognostic Biomarker for Major Adverse Cardiovascular Events in Patients with Atrial Fibrillation. International Journal of Molecular Sciences, 24(4), 3861.
https://doi.org/10.3390/ijms24043861